GZNG, a Chinese Herbal Formula, Ameliorates Metabolic Dysfunction-Associated Steatotic Liver Disease via the NR5A2-Metallothionein Axis
Authors: Cui, Enze; Fang, Jingjing; Zhu, Ying; Zheng, Tianxiao; Pei, Zhi; Gao, Xuxia; Lu, Kunliang; Guo, Jingjing; Du, Juan; Ling, Changquan; Ling, Chen
Source journal: Molecular therapy : the journal of the American Society of Gene Therapy (2026-11-20)
DOI: 10.1016/j.ymthe.2026.11.029
Abstract
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a prevalent global health burden with limited pharmacological options. Although Ganzaoning (GZN), a traditional Chinese medicine (TCM) formulation, shows therapeutic promise, the molecular mechanisms underlying this complex herbal formula remain largely elusive. In this study, we evaluated GZNG, a modified formulation incorporating ginseng leaf, in both in vitro and murine models of MASLD. GZNG ameliorated disease progression by reducing hepatic steatosis, oxidative stress, inflammation, and fibrosis. Transcriptomic analysis of GZNG-treated livers identified metallothioneins (MTs) as the most prominently induced genes. Subsequently, Liver Receptor Homolog-1 (LRH-1, also known as Nr5a2) was predicted to be the upstream transcriptional regulator driving Mt1/2 induction by promoter motif analysis and siRNA-mediated knockdown in cultured cells. Further chemical profiling and molecular modeling identified ginsenoside F3, a constituent of GZNG, as a candidate ligand occupying the ligand-binding pocket of Nr5a2. A head-to-head comparison showed that GZNG exerted more pronounced therapeutic effects than the original GZN formulation. These findings not only establish Mt1/2 as transcriptional targets of Nr5a2 but also provide molecular evidence supporting the clinical potential of GZNG, thereby bridging traditional phytomedicine with modern molecular therapeutics.
Related topics
Related open access articles
- Molecular and Thermodynamic Modeling of the Protein-Ligand Interaction. Application to Computer-Assisted Design of Anti-Competitive Inhibitors of Human Histone Deacetylase 2 (HDAC2).
- Conformational analysis and molecular design of anthranilic acid derivatives as partial agonists of the Farnesoid X Receptor (FXR) with favorable predicted pharmacokinetic profiles
- Development and Validation Molecular Docking Analysis of Human serum albumin (HSA)
- THEORETICAL INVESTIGATION OF β-CYCLODEXTRIN WITH PYRAZOLINE DERIVATIVE
- Curcumin and pipernonaline to curb diabetes the natural way: A molecular modeling, docking and dynamics simulation study
- Molecular modeling of the multiple-drug resistant protein (MRP7) and pharmacophore modelling based virtual screening to identify novel drugs against cancer
Abstract and bibliographic data from PubMed (U.S. National Library of Medicine). Copyright of the abstract belongs to the original publisher or authors.